HSBC Holdings
AGL icon

HSBC Holdings’s Agilon Health AGL Stock Holding History

HSBC Holdings’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,515
Closed -$44K – 2883
2025
Q4 		$44K Sell
2,515
-2
-0.1% -$39 ﹤0.01% 2873
2025
Q3 		$67K Sell
2,517
-1,532
-38% -$57.9K ﹤0.01% 2628
2025
Q2 		$236K Sell
4,049
-219
-5% -$17.6K ﹤0.01% 2597
2025
Q1 		$463K Sell
4,268
-1,050
-20% -$91.4K ﹤0.01% 2123
2024
Q4 		$249K Buy
5,318
+3,576
+205% +$216K ﹤0.01% 2597
2024
Q3 		$173K Buy
+1,742
New +$225K ﹤0.01% 2670
2024
Q2 		– Sell
-2,500
Closed -$381K – 2920
2024
Q1 		$381K Buy
2,500
+692
+38% +$115K ﹤0.01% 2259
2023
Q4 		$565K Buy
+1,808
New +$654K ﹤0.01% 2003
2022
Q4 		– Sell
-1,374
Closed -$829K – 3043
2022
Q3 		$829K Buy
+1,374
New +$823K ﹤0.01% 1914

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

HSBC Holdings's AGL Position: Q1 2026 in Review

HSBC Holdings sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 2,515 shares — an estimated $44K sold.

HSBC Holdings first reported a position in AGL in Q3 2022 and held it in 9 quarters. The position peaked at $829K in Q3 2022. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • HSBC Holdings reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 2,515 Agilon Health shares in Q1 2026, an estimated $44K.
  • HSBC Holdings first reported a position in Agilon Health in Q3 2022 and held it in 9 quarters.
  • HSBC Holdings's Agilon Health position peaked at $829K in Q3 2022.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.